Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

Core Viewpoint - Collegium Pharmaceutical, Inc. is set to report its fourth quarter and full-year 2025 financial results on February 26, 2026, before market opening, followed by a live conference call at 8:00 a.m. ET [1]. Group 1: Financial Reporting - The financial results for Q4 and full-year 2025 will be released before the market opens on February 26, 2026 [1]. - A live conference call and webcast will be held at 8:00 a.m. ET following the financial results announcement [1]. Group 2: Conference Call Information - To access the conference call, participants can dial (877) 407-8037 for U.S. calls or (201) 689-8037 for international calls, referencing the "Collegium Pharmaceutical Q4 2025 Earnings Call" [2]. - An audio webcast will be available on the Company's website, with a replay accessible approximately two hours after the event [2]. Group 3: Company Overview - Collegium Pharmaceutical is focused on becoming a leading, diversified biopharmaceutical company, aiming to improve the lives of individuals with serious medical conditions [3]. - The Company has a strong portfolio in responsible pain management medications and a growing neuropsychiatry business, highlighted by Jornay PM®, a unique treatment for ADHD [3]. - Collegium's strategy includes expanding its commercial portfolio with Jornay PM as the primary growth driver and managing capital deployment in a disciplined manner [3].